Evidence map›Paper›PMID 42372707›Full record

ArticleRedox biology2026

Bidirectional redox-modulating vanadium carbide-integrated smart microneedles for infected wound healing.

Zhichao Yao, Yue Zhang, Shiyang Lin, Yan Gao, Dandan Shen, Zijiu Sun, Fenyong Sun, Zhongqi Cui, Shuo Shi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zhichao YaoSchool of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, 200092, PR China.
Yue ZhangDepartment of Central Laboratory, Shanghai Tenth People's Hospital, Clinical Medicine Scientific and Technical Innovation Park, Shanghai, PR China.
Shiyang LinSchool of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, 200092, PR China.
Yan GaoSchool of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, 200092, PR China.
Dandan ShenSchool of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, 200092, PR China.
Zijiu SunSchool of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, 200092, PR China.
Fenyong SunSchool of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, 200092, PR China.
Zhongqi CuiSchool of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, 200092, PR China. Electronic address: 1632084@tongji.edu.cn.
Shuo ShiSchool of Chemical Science and Engineering, Department of Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Tongji University, Shanghai, 200092, PR China. Electronic address: shishuo@tongji.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wound healing is plagued by an inherent reactive oxygen species (ROS) paradox: elevated ROS are critical for antibacterial defense, yet excessive ROS levels impede inflammation resolution and tissue repair. Conventional single-component nanomaterials lack the capacity for bidirectional ROS regulation, while multi-drug combination strategies suffer from complex regulatory modalities, poor stability, and antimicrobial resistance issues-all of which limit clinical translation. To address these challenges, we develop a vanadium carbide (V

Indexed as

Anti-Bacterial AgentsVanadium CompoundsWound HealingWound InfectionAnimalsHumansMiceMicroneedle Drug DeliveryOxidation-ReductionReactive Oxygen SpeciesAnti-Bacterial AgentsReactive Oxygen SpeciesVanadium CompoundsAntibacterialAnti-inflammatoryBifunctional mxenesIntegrated treatmentROS regulationSoft microneedles

Identifiers

PMID42372707
PMCPMC13330685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.